Search

everythinglearnresearchcommunity

for

Search:↓

The British Association of Dermatologists celebrated 100 years by looking back at important research, including work on hair loss, skin condition impact, psoriasis treatment, and skin cancer rates.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Removing EGFR in skin causes inflammation and abnormal hair growth.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Caffeine can effectively treat hair loss and skin issues.

No treatment fully prevents hair loss from chemotherapy yet.

Indian Gooseberry has potential for cancer prevention and treatment and promotes hair growth.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

A rare case of hair loss was linked to breast cancer spreading to the scalp, but treatment was effective.

Afatinib often causes skin problems that need proactive management.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Some patients' hair grew back black and white after chemotherapy.

Inducing survivin in normal tissues can protect against radiation damage.

Topical vitamin D3 does not prevent hair loss from chemotherapy.